Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 15/20 | 0.52 |
| ▸ | PREP | P48147 | 4/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.46 |
| ▸ | FAP | Q12884 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6830208 | 0.91 | DPP4 (0.51) | DPP4PREPDPP7DPP8FAP | |
| SCHEMBL6828275 | 0.88 | PREP (0.52) | DPP4PREPDPP7DPP8FAP | |
| SCHEMBL4594463 | 0.82 | DPP4 (0.47) | DPP4PREPDPP7DPP8FAP | |
| SCHEMBL6828026 | 0.82 | DPP4 (0.47) | DPP4PREPDPP7DPP8FAP | |
| SCHEMBL4593211 | 0.82 | DPP4 (0.51) | DPP4PREPDPP7DPP8 | |
| SCHEMBL6828531 | 0.81 | DPP4 (0.62) | DPP4PREPDPP7DPP8DPP9 | |
| SCHEMBL4594040 | 0.81 | DPP4 (0.46) | DPP4PREPDPP7DPP8 | |
| SCHEMBL6827950 | 0.81 | DPP4 (0.52) | DPP4PREPDPP7DPP8FAP | |
| SCHEMBL6828021 | 0.81 | DPP4 (0.50) | DPP4PREPDPP7DPP8 | |
| SCHEMBL6827820 | 0.80 | DPP4 (0.65) | DPP4DPP7DPP8FAPDPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917001-A2 | PHARMACEUTICAL COMPOSITION COMPRISING A DPP-IV INHIBITOR | F.HOFFMANN-LA ROCHE AG (CH) | 2008-05-07 | — | — | EP | disclosed |
| WO-2007017423-A2 | PHARMACEUTICAL COMPOSITION COMPRISING A DPP-IV INHIBITOR | F. HOFFMANN-LA ROCHE AG (CH) | 2007-02-15 | — | — | WO | disclosed |